ORGANIZATION

• Kyokai Kenpo Aims to Increase Generic Usage Rate to 65.1%
  March 20, 2015

• JHSF Calls for Tax Incentives to Promote Investment in Regenerative Medicine
  March 19, 2015

• Majority of Doctors Dissatisfied with Existing Treatments for AD, Pancreatic Cancer: JHSF
  March 18, 2015

• Bone-Forming Agents Most Needed for Osteoporosis in 2025: JHSF Survey
  March 18, 2015

• JSGM President Calls for Generic Share Target of 80% by FY2020
  March 12, 2015

• Medwatcher Accuses HPV Vaccine Makers of Violating JPMA’s Promotion Code
  March 2, 2015

• JPMA to Inform Medical Institutions of New R&D Cost Disclosure Plan in April
  February 20, 2015

• AJMC Announces Guidelines for Investigator-Led Clinical Trials
  February 20, 2015

• PhRMA Sets to Make Direct Plea to Finance Minister to Drop Annual Price Cut Plan
  February 6, 2015

• Number of Contract Sales Reps Increased to 4,148 as of Oct. 2014: CSO Association
  February 4, 2015

• JPWA President Reiterates Opposition to Annual NHI Price Revisions
  February 2, 2015

• IMI, WADA Sign MOU to Prevent Use of Experimental Drugs for Doping
  January 30, 2015

• July-Sept. Generic Share Reaches 51.3% under New Formula: JGA
  January 30, 2015

• JPMA Draft Guidelines Urge Companies to Separate Ad Reviewing Bodies from Sales Units
  January 27, 2015

• Chuikyo Members Divided on Usage of Savings from NHI Price Cuts
  January 26, 2015

• 3-Price Bracket Rule for Generics Causing Various Distortions, Problems: JGA President
  January 23, 2015

• Ihoken Proposes New Pricing Rule for Regenerative Medicines
  January 22, 2015

• Some LDP Members Keen to Tackle Kampo NHI Price Problem
  January 21, 2015

• JSMI to Announce in May a “Grand Design” for OTC Drug Industry
  January 21, 2015

• JPMA Notifies of Unfavorable Expressions for Disease Awareness Ads
  January 16, 2015

ページ

• « 先頭
• ‹ Prev
• …
• 55
• 56
• 57
• 58
• 59
• 60
• 61
• 62
• 63
• …
• Next ›
• 最終 »